For example, PIK3CA was an inclusion criterion in one clinical trial (NCT02957266) for directing cervical carcinoma therapy (45), as well as, ERBB3 and FBXW7 were considered as biomarkers in several clinical trials for malignant solid tumor (Table 3). The gene discussed is ERBB3; the disease is cervical carcinoma.